Home > News > A TINY Opportunity in Nanosys' News
July 20th, 2007
A TINY Opportunity in Nanosys' News
Abstract:
Venture-capital firm Harris & Harris (Nasdaq: TINY) is a difficult company to follow, because its value resides in the two dozen-plus nanotechnology start-ups in which it has an equity stake.
For a long time, one of its more visible portfolio holdings was Nanosys, a Palo Alto, Calif.-based start-up that many thought would be the first true nanotechnology company to go public.
Well, for a variety of reasons, Nanosys failed to file for an IPO back in 2004, and as a result, it has somewhat unfairly been held up as the poster child for much of the hype that surrounded the field of nanotechnology a few years back.
An article in today's Technology Review, however, reveals that Nanosys is alive and kicking, and it has made deals with both Intel (Nasdaq: INTC) and Micron (NTSE: MU) to begin supplying its metal nanocrystals in next-generation flash memory chips as early as 2009.
Source:
fool.com
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||